ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹19,054 Cr | ₹15,953 Cr | ₹14,060 Cr | ₹12,454 Cr | ₹12,760 Cr |
What is the latest Total Liabilities ratio of ALKEM LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹19,054 Cr |
| Mar2025 | ₹15,953 Cr |
| Mar2024 | ₹14,060 Cr |
| Mar2023 | ₹12,454 Cr |
| Mar2022 | ₹12,760 Cr |
How is Total Liabilities of ALKEM LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹19,054 Cr | 19.44 | |
| Mar2025 | ₹15,953 Cr | 13.46 | |
| Mar2024 | ₹14,060 Cr | 12.89 | |
| Mar2023 | ₹12,454 Cr | -2.40 | |
| Mar2022 | ₹12,760 Cr | - | |
Compare Total Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹65,899.6 Cr | -2.7% | -1.2% | 12.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2.7% |
-1.2% |
12.9% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses